BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1292343)

  • 1. Glomerular morphometry of adriamycin-induced focal and segmental glomerulosclerosis in the rat.
    Güezmes A; Fernández F; Garijo F; Val-Bernal F
    Am J Nephrol; 1992; 12(6):437-41. PubMed ID: 1292343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerulosclerosis 4 weeks after administration of adriamycin in a single dose.
    Pedrycz A; Wieczorski M; Czerny K
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):214-9. PubMed ID: 16145983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat.
    Fries JW; Sandstrom DJ; Meyer TW; Rennke HG
    Lab Invest; 1989 Feb; 60(2):205-18. PubMed ID: 2915515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional morphometric analysis of segmental glomerulosclerosis in the rat.
    Remuzzi A; Pergolizzi R; Mauer MS; Bertani T
    Kidney Int; 1990 Nov; 38(5):851-6. PubMed ID: 2266668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo.
    Wan YG; Che XY; Sun W; Huang YR; Meng XJ; Chen HL; Shi XM; Tu Y; Wu W; Liu YL
    J Ethnopharmacol; 2014 Feb; 151(3):1079-1089. PubMed ID: 24362077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adriamycin nephropathy: a model of focal segmental glomerulosclerosis.
    Lee VW; Harris DC
    Nephrology (Carlton); 2011 Jan; 16(1):30-8. PubMed ID: 21175974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between tubulointerstitial nephropathy and glomerular lesions induced by adriamycin.
    Güezmes A; Fernández F; Garijo F; Val-Bernal F
    Nephron; 1992; 62(2):198-202. PubMed ID: 1436314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adriamycin-induced glomerulosclerosis in the rat.
    Bertani T; Rocchi G; Sacchi G; Mecca G; Remuzzi G
    Am J Kidney Dis; 1986 Jan; 7(1):12-9. PubMed ID: 3510531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adriamycin-induced focal glomerular sclerosis: pathogenetic development and alteration of glomerular epithelial cells].
    Ito K; Ger YC
    Nihon Jinzo Gakkai Shi; 1985 Aug; 27(8):1113-22. PubMed ID: 4087532
    [No Abstract]   [Full Text] [Related]  

  • 11. Adriamycin-induced chronic proteinuria: a structural and functional study.
    O'Donnell MP; Michels L; Kasiske B; Raij L; Keane WF
    J Lab Clin Med; 1985 Jul; 106(1):62-7. PubMed ID: 4009023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation. Evidence for involvement of macrophages and lipids.
    van Goor H; Fidler V; Weening JJ; Grond J
    Lab Invest; 1991 Jun; 64(6):754-65. PubMed ID: 2046327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine induces glomerulosclerosis: three-dimensional definition of the lesions in a rat model of renal transplant.
    Perico N; Detcheva A; Khalil EI; Remuzzi G
    Kidney Int; 1996 May; 49(5):1283-8. PubMed ID: 8731092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ovaries attenuate the aggravating effect of testosterone on glomerular injury in Adriamycin-induced nephropathy of female rats.
    Sakemi T; Ohtsuka N; Tomiyoshi Y; Morito F
    Kidney Blood Press Res; 1997; 20(1):44-50. PubMed ID: 9192910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A frequent pathway to glomerulosclerosis: deterioration of tuft architecture-podocyte damage-segmental sclerosis.
    Kriz W; Kretzler M; Nagata M; Provoost AP; Shirato I; Uiker S; Sakai T; Lemley KV
    Kidney Blood Press Res; 1996; 19(5):245-53. PubMed ID: 8956236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphasic glomerular hypertrophy in rats administered puromycin aminonucleoside.
    Cahill MM; Ryan GB; Bertram JF
    Kidney Int; 1996 Sep; 50(3):768-75. PubMed ID: 8872950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of urine volume ameliorates adriamycin-induced nephropathy.
    Soares VA; Viero RM
    Braz J Med Biol Res; 1993 Sep; 26(9):943-53. PubMed ID: 8298529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraglomerular proteinase activity in adriamycin-induced nephropathy.
    Paczek L; Teschner M; Schaefer RM; Kovar J; Romen W; Heidland A
    Nephron; 1992; 60(1):81-6. PubMed ID: 1738419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of captopril on morphologic changes in kidney of spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D; Dimitrijevic J; Varagic J; Jovovic D; Starcevic A; Djukanovic L
    Ren Fail; 1998 May; 20(3):451-8. PubMed ID: 9606733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro-CT imaging and structural analysis of glomeruli in a model of Adriamycin-induced nephropathy.
    Xie L; Koukos G; Barck K; Foreman O; Lee WP; Brendza R; Eastham-Anderson J; McKenzie BS; Peterson A; Carano RAD
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F76-F89. PubMed ID: 30256127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.